NM_014908.4:c.631C>T
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2
The NM_014908.4(DOLK):c.631C>T(p.Arg211Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00332 in 1,614,128 control chromosomes in the GnomAD database, including 19 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_014908.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -13 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DOLK | NM_014908.4 | c.631C>T | p.Arg211Cys | missense_variant | Exon 1 of 1 | ENST00000372586.4 | NP_055723.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00233 AC: 355AN: 152120Hom.: 2 Cov.: 31
GnomAD3 exomes AF: 0.00189 AC: 476AN: 251394Hom.: 1 AF XY: 0.00199 AC XY: 271AN XY: 135870
GnomAD4 exome AF: 0.00342 AC: 5003AN: 1461890Hom.: 17 Cov.: 31 AF XY: 0.00332 AC XY: 2417AN XY: 727246
GnomAD4 genome AF: 0.00233 AC: 354AN: 152238Hom.: 2 Cov.: 31 AF XY: 0.00195 AC XY: 145AN XY: 74436
ClinVar
Submissions by phenotype
not provided Uncertain:1Benign:2
- -
This variant is associated with the following publications: (PMID: 23757202) -
DOLK: BS2 -
DK1-congenital disorder of glycosylation Uncertain:1Benign:1
This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -
- -
not specified Benign:2
p.Arg211Cys in exon 1 of DOLK: This variant is not expected to have clinical sig nificance because it has been identified in 0.2% (162/66700) of European chromos omes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs145310298). Additionally, arginine (Arg) at position 211 is not conserve d in mammals or evolutionarily distant species, and 2 mammals (cape elephant shr ew and aardvark) carry a cysteine (Cys) despite high nearby amino acid conservat ion. -
Variant summary: DOLK c.631C>T (p.Arg211Cys) results in a non-conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.0019 in 251394 control chromosomes in the gnomAD database, including 1 homozygote. The observed variant frequency is approximately 1.69 fold of the estimated maximal expected allele frequency for a pathogenic variant in DOLK causing DK1-Congenital Disorder Of Glycosylation (0.0011), strongly suggesting that the variant is benign. To our knowledge, no occurrence of c.631C>T in individuals affected with DK1-Congenital Disorder Of Glycosylation and no experimental evidence demonstrating its impact on protein function have been reported. Six submitters have cited clinical-significance assessments for this variant to ClinVar after 2014; five submitters classified the variant as likely benign and one classified it as a variant of uncertain significance. Based on the evidence outlined above, the variant was classified as likely benign. -
Cardiovascular phenotype Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at